A sensitive method to quantify human cell-free circulating DNA in blood: relevance to myocardial infarction screening
- PMID: 21723272
- DOI: 10.1016/j.clinbiochem.2011.06.083
A sensitive method to quantify human cell-free circulating DNA in blood: relevance to myocardial infarction screening
Abstract
Objectives: Human cell-free circulating DNA (cf-DNA) derived mainly from cell apoptosis and necrosis can be measured by a variety of laboratory techniques, but almost all of these methods require sample preparation. We have developed a branched DNA (bDNA)-based Alu assay for quantifying cf-DNA in myocardial infarction (MI) patients.
Design and methods: A total of 82 individuals were included in the study; 22 MI and 60 normal controls. cf-DNA was quantified using a bDNA-based Alu assay.
Results: cf-DNA was higher in serum compared to plasma and there was a difference between genders. cf-DNA was significantly higher in MI patients compared to the controls. There was no correlation between cf-DNA and creatine kinase-MB (CK-MB), troponin I (cTnI) or myoglobin (MYO). In serial specimens, cf-DNA was sensitive and peaked earlier than cTnI.
Conclusions: The bDNA-based Alu assay is a novel method for quantifying human cf-DNA. Increased cf-DNA in MI patients might complement cTnI, CK-MB and MYO in a multiple marker format.
Copyright © 2011 The Canadian Society of Clinical Chemists. All rights reserved.
Similar articles
-
A novel Alu-based real-time PCR method for the quantitative detection of plasma circulating cell-free DNA: sensitivity and specificity for the diagnosis of myocardial infarction.Int J Mol Med. 2015 Jan;35(1):72-80. doi: 10.3892/ijmm.2014.1991. Epub 2014 Nov 5. Int J Mol Med. 2015. PMID: 25374065 Free PMC article.
-
Elevated cell-free serum DNA detected in patients with myocardial infarction.Clin Chim Acta. 2003 Jan;327(1-2):95-101. doi: 10.1016/s0009-8981(02)00337-6. Clin Chim Acta. 2003. PMID: 12482623
-
Impact of the troponin standard on the prevalence of acute myocardial infarction.Am Heart J. 2003 Sep;146(3):446-52. doi: 10.1016/S0002-8703(03)00245-X. Am Heart J. 2003. PMID: 12947361
-
Cardiac markers in the assessment of acute coronary syndromes.Md Med J. 1997;Suppl:18-24. Md Med J. 1997. PMID: 9470339 Review.
-
Laboratory diagnosis of patients with acute chest pain.Clin Chem Lab Med. 2000 Mar;38(3):187-97. doi: 10.1515/CCLM.2000.027. Clin Chem Lab Med. 2000. PMID: 10905753 Review.
Cited by
-
Plasma nuclear and mitochondrial DNA levels in acute myocardial infarction patients.Coron Artery Dis. 2015 Jun;26(4):296-300. doi: 10.1097/MCA.0000000000000231. Coron Artery Dis. 2015. PMID: 25714070 Free PMC article.
-
Alu-based cell-free DNA: a novel biomarker for screening of gastric cancer.Oncotarget. 2016 Aug 5;8(33):54037-54045. doi: 10.18632/oncotarget.11079. eCollection 2017 Aug 15. Oncotarget. 2016. PMID: 28903321 Free PMC article.
-
The Factors Predicting Concordant Epidermal Growth Factor Receptor (EGFR) Mutation Detected in Liquid/Tissue Biopsy and the Related Clinical Outcomes in Patients of Advanced Lung Adenocarcinoma with EGFR Mutations.J Clin Med. 2019 Oct 23;8(11):1758. doi: 10.3390/jcm8111758. J Clin Med. 2019. PMID: 31652678 Free PMC article.
-
A novel Alu-based real-time PCR method for the quantitative detection of plasma circulating cell-free DNA: sensitivity and specificity for the diagnosis of myocardial infarction.Int J Mol Med. 2015 Jan;35(1):72-80. doi: 10.3892/ijmm.2014.1991. Epub 2014 Nov 5. Int J Mol Med. 2015. PMID: 25374065 Free PMC article.
-
Clinical and biological determinants of circulating tumor DNA detection and prognostication using a next-generation sequencing panel assay.Cancer Biol Ther. 2021 Sep 2;22(7-9):455-464. doi: 10.1080/15384047.2021.1963166. Epub 2021 Aug 14. Cancer Biol Ther. 2021. PMID: 34392779 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
